Hepatology
From the Journals
Opioid use higher in adults with health conditions
Patients with cirrhosis are nearly twice as likely as are those without the condition to use prescription opioids.
News
FDA advisory panel backs safety of new hepatitis B vaccine for adults
A new, two-dose hepatitis B vaccine is given the nod of approval for further study.
News
FDA approves new treatment for adults with HCV
Results of two trials showed that 96%-97% of patients who received Vosevi had no virus detected in the blood 12 weeks after finishing treatment
From the Journals
Liver cancer risk lower after sustained response to DAAs
DAAs may reduce prevalence of hepatocellular carcinoma among patients with hepatitis C.
Opinion
Hepatitis C is a pediatric disease now
The baby looked perfect: healthy term male, weight at the 60th percentile, normal exam. The mother, a 26-year-old diagnosed with hepatitis C virus...
From the Journals
Liver disease doubles risk of colorectal cancer
New screening recommendations for patients with chronic liver diseases are now being considered.
Conference Coverage
HCV/HIV-coinfected teens rapidly progress to advanced liver disease
MADRID – Nearly one-quarter of HCV/HIV-coinfected teens have advanced hepatic fibrosis by age 20.
From the Journals
Relatives of NAFLD patients: 12-fold higher risk
Close relative with nonalcoholic fatty liver disease indicates risk.
From the Journals
Steatosis linked to persistent ALT increase in hepatitis B
Elevated alanine aminotransferase levels often persist despite successful antiviral treatment.
From the Journals
Distance from transplant center predicted mortality in chronic liver disease
The findings underscore the need for accessible, specialized liver care irrespective of whether patients with chronic liver failure are destined...
News from the FDA/CDC
Few states fully back HCV prevention, treatment
Seven states have twice the national rate of hepatitis C incidence, but only three have comprehensive prevention laws and permissive treatment...